BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 2178330)

  • 1. Effects of treatment on long-term survivors with malignant astrocytomas.
    Imperato JP; Paleologos NA; Vick NA
    Ann Neurol; 1990 Dec; 28(6):818-22. PubMed ID: 2178330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Fukushima T; Yamamoto M; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 1998; 18(5D):3965-70. PubMed ID: 9854511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
    Vitanovics D; Sipos L; Afra D
    Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.
    López-Aguilar E; Sepúlveda-Vildósola AC; Rivera-Márquez H; Cerecedo-Díaz F; Hernández-Contreras I; Ramón-García G; Diegopérez-Ramírez J; Santacruz-Castillo E
    Arch Med Res; 2000; 31(2):186-90. PubMed ID: 10880725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized tomography in the prognosis of malignant cerebral gliomas.
    Murovic J; Turowski K; Wilson CB; Hoshino T; Levin V
    J Neurosurg; 1986 Dec; 65(6):799-806. PubMed ID: 3021932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of anaplastic changes in low-grade astrocytomas of childhood.
    Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
    Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma.
    Phuphanich S; Scott C; Fischbach AJ; Langer C; Yung WK
    J Neurooncol; 1997 Sep; 34(2):193-200. PubMed ID: 9210068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of pretreatment CT scans in supratentorial astrocytomas receiving radiotherapy].
    Shimizu M; Yamada S; Takai Y; Sasauchi S; Tazawa S; Shimanuki Y; Sakurai H; Katakura R
    Gan No Rinsho; 1987 Mar; 33(3):237-41. PubMed ID: 3035252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron capture therapy. Clinical brain tumor studies.
    Nakagawa Y; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):105-15. PubMed ID: 9151228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.
    Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation of infratentorial and supratentorial brain-stem tumors.
    Lee F
    J Neurosurg; 1975 Jul; 43(1):65-8. PubMed ID: 167136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.
    Madajewicz S; Chowhan N; Tfayli A; Roque C; Meek A; Davis R; Wolf W; Cabahug C; Roche P; Manzione J; Iliya A; Shady M; Hentschel P; Atkins H; Braun A
    Cancer; 2000 May; 88(10):2350-6. PubMed ID: 10820358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy of astrocytoma].
    Koga K; Nishikawa K; Watanabe K; Wakisaka S
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2546-50. PubMed ID: 2850329
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging response in malignant glioma, RTOG 90-06.
    Lustig RA; Seiferheld W; Berkey B; Yung AW; Scarantino C; Movsas B; Jones CU; Simpson JR; Fishbach J; Curran WJ
    Am J Clin Oncol; 2007 Feb; 30(1):32-7. PubMed ID: 17278892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoradiation for malignant brain tumors].
    Matsutani M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2042-8. PubMed ID: 9388512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.